Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment

References

• Bao Q, Hu P, Xu Y, et al. (2018). Simultaneous blood-brain barrier crossing and protection for stroke treatment based on edaravone-loaded ceria nanoparticles. ACS Nano 12:6794–805.
   PubMed Web of Science ®Google Scholar
• Barbara R, Belletti D, Pederzoli F, et al. (2017). Novel Curcumin loaded nanoparticles engineered for blood-brain barrier crossing and able to disrupt Abeta aggregates. Int J Pharm 526:413–24.
   PubMed Web of Science ®Google Scholar
• Basu T, Singh S, Pal B. (2018). PLGA-PEG nanocomposite for improved delivery of methotrexate in cancer treatment. ChemistrySelect 3:8522–8.
   Web of Science ®Google Scholar
• Chen H, Tang L, Qin Y, et al. (2010). Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery. Eur J Pharm Sci 40:94–102.
   PubMed Web of Science ®Google Scholar
• Dong X. (2018). Current strategies for brain drug delivery. Theranostics 8:1481–93.
   PubMed Web of Science ®Google Scholar
• Español L, Larrea A, Andreu V, et al. (2016). Dual encapsulation of hydrophobic and hydrophilic drugs in PLGA nanoparticles by a single-step method: Drug delivery and cytotoxicity assays. RSC Adv 6:111060–9.
   Web of Science ®Google Scholar
• Ficai D, Grumezescu V, Mariana O, et al. (2018). Antibiofilm coatings based on PLGA and nanostructured cefepime-functionalized magnetite. Nanomaterials (Basel) 8:633.
   PubMedGoogle Scholar
• Filippousi M, Altantzis T, Stefanou G, et al. (2013). Polyhedral iron oxide core–shell nanoparticles in a biodegradable polymeric matrix: preparation, characterization and application in magnetic particle hyperthermia and drug delivery. RSC Adv 3:24367–77.
   Web of Science ®Google Scholar
• Frigell J, Garcia I, Gómez-Vallejo V, et al. (2014). 68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation. J Am Chem Soc 136:449–57.
   PubMed Web of Science ®Google Scholar
• Grumezescu V, Gherasim O, Negut I, et al. (2019). Nanomagnetite-embedded PLGA spheres for multipurpose medical applications. Materials (Basel). 12:2521.
   PubMed Web of Science ®Google Scholar
• Han L, Cai Q, Tian D, et al. (2016). Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles. Nanomed-Nanotechol. 12:1833–42.
   Google Scholar
• Hawkins BT, Davis TP. (2005). The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173–85.
   PubMed Web of Science ®Google Scholar
• Inbaraj BS, Chen BH. (2012). In vitro removal of toxic heavy metals by poly(γ-glutamic acid)-coated superparamagnetic nanoparticles. Int J Nanomedicine 7:4419–32.
   PubMed Web of Science ®Google Scholar
• Jahangirian H, Lemraski EG, Webster TJ, et al. (2017). A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine. Int J Nanomedicine 12:2957–78.
   PubMed Web of Science ®Google Scholar
• Jiang AX, Andjelkovic AV, Zhu L, et al. (2018). Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol 163–164:144–171.
   PubMed Web of Science ®Google Scholar
• Jiang X. (2013). Brain drug delivery systems. Pharm Res 30:2427–8.
   PubMed Web of Science ®Google Scholar
• Komane PP, Kumar P, Marimuthu T, et al. (2018). Dexamethasone-loaded, PEGylated, vertically aligned, multiwalled carbon nanotubes for potential ischemic stroke intervention. Molecules 23:1406.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2014). Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 71:2–14.
   PubMed Web of Science ®Google Scholar
• Kyle S, Saha S. (2014). Nanotechnology for the detection and therapy of stroke. Adv Healthc Mater 3:1703–20.
   PubMed Web of Science ®Google Scholar
• Liu L, Venkatraman SS, Yang YY, et al. (2008). Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier. Biopolymers 90:617–23.
   PubMed Web of Science ®Google Scholar
• Majeed MI, Lu Q, Yan W, et al. (2013). Highly water-soluble magnetic iron oxide (Fe3O4) nanoparticles for drug delivery: enhanced in vitro therapeutic efficacy of doxorubicin and MION conjugates. J Mater Chem B 1:2874–84.
   PubMed Web of Science ®Google Scholar
• Mc Carthy DJ, Malhotra M, O'Mahony AM, et al. (2015). Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance. Pharm Res 32:1161–85.
   PubMed Web of Science ®Google Scholar
• Mcnamara K, Tofail SAM, Mcnamara K, Tofail SAM. (2017). Nanoparticles in biomedical applications. Adv Phys X 2:1–35.
   Google Scholar
• Oller-Salvia B, Sánchez-Navarro M, Giralt E, Teixidó M. (2016). Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery. Chem Soc Rev 45:4690–707.
   PubMed Web of Science ®Google Scholar
• Papadimitriou S, Bikiaris D. (2009). Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release. J Control Release 138:177–84.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (2007). Blood-brain barrier delivery. Drug Discov Today 12:54–61.
   PubMed Web of Science ®Google Scholar
• Patel MM, Patel BM. (2017). Crossing the blood-brain barrier: recent advances in drug delivery to the brain. CNS Drugs 31:109–33.
   PubMed Web of Science ®Google Scholar
• Patel T, Zhou J, Piepmeier JM, Saltzman WM. (2012). Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev 64:701–5.
   PubMed Web of Science ®Google Scholar
• Qiao R, Jia Q, Hüwel S, et al. (2012). Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. ACS Nano 6:3304–10.
   PubMed Web of Science ®Google Scholar
• Rhim T, Lee DY, Lee M. (2013). Drug delivery systems for the treatment of ischemic stroke. Pharm Res 30:2429–44.
   PubMed Web of Science ®Google Scholar
• Sacco RL, Kasner SE, Broderick JP, et al. (2013). AHA/ASA expert consensus document an updated definition of stroke for the 21st century. Stroke 44:2064–89.
   PubMed Web of Science ®Google Scholar
• Saeedi M, Eslamifar M, Khezri K, Maleki S. (2019). Applications of nanotechnology in drug delivery to the central nervous system. Biomed Pharmacother 111:666–75.
   PubMed Web of Science ®Google Scholar
• Saraiva C, Praça C, Ferreira R, et al. (2016). Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release 235:34–47.
   PubMed Web of Science ®Google Scholar
• Shagholani H, Ghoreishi SM, Mousazadeh M. (2015). Improvement of interaction between PVA and chitosan via nanoparticles for drug delivery application. Int J Biol Macromol 78:130–36.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhu Y, Huang C, et al. (2016). Magnetite loaded Polypeptide-PLGA multifunctional microbubbles for dual-mode US/MR imaging. Contrast Media Mol Imaging 11:146–53.
   Google Scholar
• Thompson BJ, Ronaldson PT. (2014). Drug delivery to the ischemic brain. Adv Pharmacol 71:165–202.
   Google Scholar
• Thomsen LB, Linemann T, Pondman KM, et al. (2013). Uptake and transport of superparamagnetic iron oxide nanoparticles through human brain capillary endothelial cells. ACS Chem Neurosci 4:1352–60.
   PubMed Web of Science ®Google Scholar
• Wanawananon K, Moulton SE, Wallace GG, Liawruangrath S. (2016). Fabrication of novel core–shell PLGA and alginate fiber for dual-drug delivery system. Polym Adv Technol 27:1014–9.
   Web of Science ®Google Scholar
• Xie J, Shen Z, Anraku Y, et al. (2019). Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials 224:119491–511.
   PubMed Web of Science ®Google Scholar
• Yang C, Hawkins KE, Doré S, Candelario-jalil E. (2019). Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol 316:C135–53.
   PubMed Web of Science ®Google Scholar
• Yang Q, Lan F. (2014). Hollow superparamagnetic PLGA/Fe3O4 composite microspheres for lysozyme adsorption. Nanotechnology 25:085702.
   PubMed Web of Science ®Google Scholar
• Yim YS, Choi JS, Kim GT, et al. (2012). A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood-brain barrier (BBB). Chem Commun (Camb) 48:61–3.
   PubMed Web of Science ®Google Scholar
• You L, Liu X, Fang Z, et al. (2019). Synthesis of multifunctional Fe3O4@PLGA-PEG nano-niosomes as a targeting carrier for treatment of cervical cancer. Mater Sci Eng C Mater Biol Appl 94:291–302.
   PubMed Web of Science ®Google Scholar